Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an ...

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. The ETF industry ...

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. While an ...

The Vanguard Health Care ETF has recently lost momentum ... What the fund does offer, however, is a heavy load of biotech stocks like Eli Lilly and Regeneron Pharmaceuticals Inc. (REGN), which ...

SBI Securities Co. Ltd. purchased a new position in VanEck Biotech ETF (NASDAQ:BBH – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ieq Capital LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and ...

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Legend Biotech (LEGN – Research Report) today. The company’s shares ...

the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice ...